Skip to main content
SleepCited

Kava के लिए Hyperarousal and Cognitive Insomnia

A

Based on 23 studies (4 meta-analyses, 1 RCT) with 2,043 total participants. Results are mixed across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dkava\u0026condition\u003Dhyperarousal\u002Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Based on 23 studies (4 meta-analyses, 1 RCT) with 2,043 total participants. Results are mixed across studies.

Key Study Findings

Case Reports n=1 6 weeks
Diagnosing Acute Kava Dermopathy: A Case Report of a Characteristic Cutaneous Eruption.
Dose: None बनाम: None Outcome: acute kava dermopathy with sebaceous gland necrosis प्रभाव: None None

जनसंख्या: 41-year-old Australian woman consuming kava for anxiety and insomnia

Case Reports n=1 Open-label
Severe kava withdrawal managed with phenobarbital.
Dose: None बनाम: None Outcome: Resolution of kava withdrawal symptoms प्रभाव: None None

जनसंख्या: 45-year-old man with kava and kratom withdrawal

Other Double-blind
The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and …
Dose: AB-free kava extract बनाम: Placebo Outcome: Tobacco cessation via stress/insomnia management प्रभाव: None None

जनसंख्या: Adult smokers (trial protocol)

Controlled Clinical Trial
Acute oral toxicity, antinociceptive and antimicrobial activities of kava dried extracts and synthetic kavain.
Dose: None बनाम: Vehicle control Outcome: Acute oral toxicity, antinociceptive activity प्रभाव: None None

जनसंख्या: Animal model

Systematic Review
The Impact of Complementary and Alternative Medicine on Insomnia: A Systematic Review.
Dose: None बनाम: None Outcome: Sleep quality improvement प्रभाव: None None

जनसंख्या: Insomnia patients

Review
Calm Down With Kava: What Clinicians Need to Know.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Kava users

Key Statistics

23

अध्ययन

2043

प्रतिभागी

Mixed

A

ग्रेड

Referenced Papers

The American journal … 2025 1 उद्धरण
Journal of clinical … 2022 27 उद्धरण
Journal of psychosocial … 2022 2 उद्धरण
Combinatorial chemistry & … 2021 16 उद्धरण
Chemical research in … 2019 6 उद्धरण
Journal of medicinal … 2018 19 उद्धरण
Sleep medicine reviews 2015 152 उद्धरण
Advances in pharmacological … 2011 79 उद्धरण
Journal of psychopharmacology … 2005 176 उद्धरण
Integrative cancer therapies 2004 59 उद्धरण
Human psychopharmacology 2003 45 उद्धरण
Phytotherapy research : … 2001 74 उद्धरण
Human psychopharmacology 2001 52 उद्धरण
Der Hautarzt; Zeitschrift … 1996 22 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

sleep:
120-250 mg kavalactones/day, 1-2 hrs before bed

अधिकतम सीमा: 250 mg kavalactones/day (European guidelines); limited to 3 months continuous use

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None 6 weeks Negative 1
None -- Positive 1
AB-free kava extract -- Mixed --
None -- Positive --
None -- Mixed --
None -- Mixed --
None -- Mixed --
not specified -- Positive --

सेवन का सर्वोत्तम समय: 1-2 hours before bed; avoid daily use beyond 3 months without medical supervision

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Drowsiness and reduced coordination
  • Hepatotoxicity (rare but serious — consult healthcare provider)
  • Skin rash (kava dermopathy) with chronic high-dose use
  • GI discomfort

ज्ञात अंतःक्रियाएँ

  • Alcohol — increased hepatotoxicity risk and CNS depression
  • Hepatotoxic medications (acetaminophen, statins) — additive liver stress
  • Benzodiazepines and sedatives — additive CNS depression
  • CYP450 substrates (2E1, 1A2, 2D6) — kavalactones may inhibit metabolism
  • Levodopa and dopaminergic drugs — kava may reduce efficacy

सहनीय अधिकतम सेवन: 250 mg kavalactones/day (European guidelines); limited to 3 months continuous use

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Kava help with Hyperarousal and Cognitive Insomnia?
Based on 23 studies with 2,043 participants, there is strong evidence from multiple clinical trials that Kava may support Hyperarousal and Cognitive Insomnia management. Our evidence grade is A (Strong Evidence).
How much Kava should I take for Hyperarousal and Cognitive Insomnia?
Studies have used various dosages. A commonly studied range is 120-250 mg kavalactones/day, 1-2 hrs before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Kava?
Reported side effects may include Drowsiness and reduced coordination, Hepatotoxicity (rare but serious — consult healthcare provider), Skin rash (kava dermopathy) with chronic high-dose use, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Kava and Hyperarousal and Cognitive Insomnia?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 23 peer-reviewed studies with 2,043 total participants. The overall direction of effect is mixed.

Related Evidence

इसके लिए अन्य सामग्री Hyperarousal and Cognitive Insomnia

Kava अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।